Chemotherapeutic implications of polyamine biosynthesis inhibition.
D000818:Animals; D004341:Drug Evaluation; D000518:Eflornithine; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D008875:Middle Aged; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000096:biosynthesis*; D011528:Protozoan Infections / Q000188:drug therapy; D014353:Trypanosomiasis, African / Q000188:drug therapy*
D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D009952:Ornithine; D000518:Eflornithine